EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Leveraging peptides for targeted protein degradation

Yuyang Li iD, Xiaowei Wang, Xinyu Wang, Ren-Shuai Zhang, Zhuo Zhang, Xue Wei Cao, Jing Rui Li, Lili Yang

Journal of Pharmacy and Pharmacology · 03.07.2026 · 78 (7)

DOI: 10.1093/jpp/rgag076 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 23.07.2026. Verfasst von Yuyang Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathobiology and Immunological Testing, School of Medical Laboratory, Qilu Medical University, Zibo 255300, China. Hauptthemen laut MEDLINE: Peptides, Proteolysis, Drug Delivery Systems, Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 96 Literaturangaben. Gefördert von: Qilu Medical University Research Project, Zibo Municipal Medical and Health Scientific Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Targeted protein degradation (TPD) technology, with a particular emphasis on proteolysis-targeting chimeras (PROTAC), has emerged as a pivotal advancement in the field of drug discovery. However, several challenges—including the identification of suitable ligands for traditionally undruggable proteins, issues related to poor solubility and permeability, nonspecific biodistribution, and off-target toxicity—have significantly hindered their clinical translation. Peptides, recognized for their ability to serve as promising ligands for broad molecular recognition, exhibit unique potential to address these limitations in TPD applications.

Methods

Literature and related information were collected from online resources such as Google Scholar, Web of Science, PubMed, CNKI, Baidu Scholar, and X-mol. Key findings Recent advancements in peptide-mediated TPD have shown promise in overcoming these challenges as researchers focus on engineering highly selective peptides that enhance binding affinity for traditionally undruggable proteins while optimizing their solubility and permeability, with next-generation delivery systems also developed to reduce nonspecific biodistribution and off-target toxicity, thereby improving the therapeutic potential of peptide-based TPD approaches.

Conclusions

This review summarizes recent advancements in peptide-based PROTAC development, focusing on innovative delivery strategies and methods for enhancing efficiency, while also offering insights into future prospects aimed at optimizing therapeutic precision and efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeptidesProteolysisDrug Delivery SystemsProteinsHumansProteolysis Targeting ChimeraAnimalsDrug DiscoveryLigandsSolubilityTissue Distribution

Stichwörter der Autor:innen

chaperone-mediated autophagylysosome targeting chimeraoptimization of delivery and efficacypeptide-based PROTACtargeted protein degradation

Substanzen

PeptidesProteolysis Targeting ChimeraLigandsProteins

Autor:innen und Institutionen

  • Department of Clinical Pathobiology and Immunological Testing, School of Medical Laboratory, Qilu Medical University, Zibo 255300, China.
  • Department of Anesthesiology, Pingdu Traditional Chinese Medicine Hospital, Pingdu 266700, China.
  • Center for Cell Structure and Function, Shandong Provincial Key Laboratory of Animal Resistance Biology, Center for Cell Structure and Function, College of Life Sciences, Shandong Normal University, Jinan 250014, China.
  • Department of Biological Sciences, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255000, China.

ORCID-Profile: Yuyang Li

Förderung

  • Qilu Medical University Research Project
  • Zibo Municipal Medical and Health Scientific Research Project

Zitieren

APA

Li, Y., Wang, X., Wang, X., Zhang, R. S., Zhang, Z., Cao, X. W., Li, J. R., & Yang, L. (2026). Leveraging peptides for targeted protein degradation. Journal of Pharmacy and Pharmacology, 78(7). https://doi.org/10.1093/jpp/rgag076

Vancouver

Li Y, Wang X, Wang X, Zhang RS, Zhang Z, Cao XW, et al. Leveraging peptides for targeted protein degradation. Journal of Pharmacy and Pharmacology. 2026;78(7). doi:10.1093/jpp/rgag076

BibTeX
@article{Li2026,
  author = {Li, Yuyang and Wang, Xiaowei and Wang, Xinyu and Zhang, Ren-Shuai and Zhang, Zhuo and Cao, Xue Wei and Li, Jing Rui and Yang, Lili},
  title = {Leveraging peptides for targeted protein degradation},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2026},
  volume = {78},
  number = {7},
  doi = {10.1093/jpp/rgag076}
}
Kostenlos starten →